Industry Experts

Mario David Saltarelli, MD, PhD is the Chief Executive Officer and Chief Medical Officer of GABA Therapeutics, an atai Life Sciences platform company focused on developing novel treatments for psychiatric and neurological disorders. He brings over 25 years of biopharmaceutical industry experience, having held senior leadership roles at companies including Pfizer, AbbVie, Annexon, and Syntimmune. Dr. Saltarelli has extensive expertise across clinical development, regulatory strategy, and corporate growth, and is leading the advancement of GABA’s pipeline, including its lead program targeting anxiety, depression, and other CNS disorders.